AuditorJun 16, 2026, 04:46 PM
NovaBridge Biosciences Changes Auditors, Appoints Deloitte
AI Summary
NovaBridge Biosciences announced a change in its independent registered public accounting firm. On June 16, 2026, the Audit Committee dismissed PricewaterhouseCoopers LLP (PwC) and immediately appointed Deloitte Touche Tohmatsu Certified Public Accountants LLP (Deloitte) for the fiscal year ending December 31, 2026. The company stated there were no disagreements with PwC on accounting or auditing matters, other than previously reported material weaknesses related to ineffective information technology general controls (ITGCs).
Key Highlights
- NovaBridge Biosciences dismissed PricewaterhouseCoopers LLP (PwC) as its independent registered public accounting firm, effective June 16, 2026.
- PwC's reports for fiscal years 2025 and 2024 did not contain adverse opinions or disclaimers.
- No disagreements with PwC on accounting principles, financial statement disclosure, or auditing scope, except for material weaknesses in ITGCs reported in 2025 and 2024.
- NovaBridge Biosciences appointed Deloitte Touche Tohmatsu Certified Public Accountants LLP (Deloitte) as its new independent registered public accounting firm for fiscal year 2026, effective immediately.
- The Company did not consult Deloitte on accounting principles or audit opinions prior to the appointment.
Price Impact
More from NBP